Kudos to The Wall Street Journal, which broke the news on the night of Oct. 21 on its Web site that “The Securities and Exchange Commission’s enforcement staff has informed Martha Stewart that it intends to recommend filing civil securities fraud charges against her in connection with her controversial sale of ImClone Systems. . .”